LEADER 01866nam  2200433Ia 450 
001 9910698807403321
005 20090604163702.0
035   $a(CKB)5470000002397796
035   $a(OCoLC)370471736
035   $a(EXLCZ)995470000002397796
100   $a20090604d2009      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $euse of serological tests to reduce the risk of transmission of trypanosoma cruzi infection in whole blood and blood components for transfusion and human cells, tissues, and cellular and tissue-based products (HCT/Ps)
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,$d[2009]
215   $ai, 14 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on June 4, 2009).
300   $a"Draft guidance".
300   $a"March 2009".
300   $aIncludes bibliographical references (p. 12-14).
517   $aGuidance for industry 
606   $aTrypanosoma cruzi$zUnited States$xPrevention
606   $aBlood$xTransfusion$xGovernment policy$zUnited States
606   $aCell transplantation$xGovernment policy$zUnited States
606   $aTransplantation of organs, tissues, etc$xGovernment policy$zUnited States
615  0$aTrypanosoma cruzi$xPrevention.
615  0$aBlood$xTransfusion$xGovernment policy
615  0$aCell transplantation$xGovernment policy
615  0$aTransplantation of organs, tissues, etc.$xGovernment policy
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698807403321
996   $aGuidance for industry$93434577
997   $aUNINA